REPORT ID 3813

EMEA (Europe, Middle East and Africa) Nonsteroidal Antiinflammatory Drugs Market Report 2017

Publish Date
14-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Nonsteroidal Antiinflammatory Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Nonsteroidal Antiinflammatory Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nonsteroidal Antiinflammatory Drugs market competition by top manufacturers/players, with Nonsteroidal Antiinflammatory Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi S.A.
    Novartis AG
    GlaxoSmithKline PLC
    Pfizer
    DOMESCO
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Oral
    Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Osteoarthritis
    Muscle Aches
    Backaches
    Dental Pain
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Nonsteroidal Antiinflammatory Drugs Market Report 2017
1 Nonsteroidal Antiinflammatory Drugs Overview
    1.1 Product Overview and Scope of Nonsteroidal Antiinflammatory Drugs
    1.2 Classification of Nonsteroidal Antiinflammatory Drugs
        1.2.1 EMEA Nonsteroidal Antiinflammatory Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Nonsteroidal Antiinflammatory Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Oral
        1.2.4 Injection
    1.3 EMEA Nonsteroidal Antiinflammatory Drugs Market by Application/End Users
        1.3.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Osteoarthritis
        1.3.3 Muscle Aches
        1.3.4 Backaches
        1.3.5 Dental Pain
        1.3.6 Others
    1.4 EMEA Nonsteroidal Antiinflammatory Drugs Market by Region
        1.4.1 EMEA Nonsteroidal Antiinflammatory Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Nonsteroidal Antiinflammatory Drugs (2012-2022)
        1.5.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Nonsteroidal Antiinflammatory Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Nonsteroidal Antiinflammatory Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Nonsteroidal Antiinflammatory Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Nonsteroidal Antiinflammatory Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Nonsteroidal Antiinflammatory Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Nonsteroidal Antiinflammatory Drugs (Volume) by Application
    2.4 EMEA Nonsteroidal Antiinflammatory Drugs (Volume and Value) by Region
        2.4.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Nonsteroidal Antiinflammatory Drugs Sales Price by Region (2012-2017)

3 Europe Nonsteroidal Antiinflammatory Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Nonsteroidal Antiinflammatory Drugs Sales and Value (2012-2017)
        3.1.1 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type
    3.3 Europe Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application
    3.4 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)

4 Middle East Nonsteroidal Antiinflammatory Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Nonsteroidal Antiinflammatory Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type
    4.3 Middle East Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application
    4.4 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)

5 Africa Nonsteroidal Antiinflammatory Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Nonsteroidal Antiinflammatory Drugs Sales and Value (2012-2017)
        5.1.1 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type
    5.3 Africa Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application
    5.4 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)

6 EMEA Nonsteroidal Antiinflammatory Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Sanofi S.A.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis AG
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GlaxoSmithKline PLC
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 DOMESCO
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    ...

7 Nonsteroidal Antiinflammatory Drugs Manufacturing Cost Analysis
    7.1 Nonsteroidal Antiinflammatory Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Nonsteroidal Antiinflammatory Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Nonsteroidal Antiinflammatory Drugs Market Forecast (2017-2022)
    11.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Nonsteroidal Antiinflammatory Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Nonsteroidal Antiinflammatory Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Nonsteroidal Antiinflammatory Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer